Type 1 iodothyronine deiodinase (DIO1) regulates peripheral metabolism of thyroid hormones that control cellular proliferation, differentiation and metabolism. The significance of DIO1 in cancer is unknown. In this study we hypothesized that diminished expression of DIO1, observed in renal cancer, contributes to the carcinogenic process in the kidney. Here, we demonstrate that ectopic expression of DIO1 in renal cancer cells changes the expression of genes controlling cell cycle, including cyclin E1 and E2F5, and results in inhibition of proliferation. The expression of genes encoding collagens (COL1A1, COL4A2, COL5A1), integrins (ITGA4, ITGA5, ITGB3) and transforming growth factor-β-induced (TGFBI) is significantly altered in renal cancer cells with induced expression of DIO1. Finally, we show that overexpression of DIO1 inhibits migration of renal cancer cells. In conclusion, we demonstrate for the first time that loss of DIO1 contributes to renal carcinogenesis and that its induced expression protects cells against cancerous proliferation and migration.

Additional Metadata
Keywords Adhesion, Migration, Proliferation, Renal cancer, Type 1 iodothyronine deiodinase
Persistent URL dx.doi.org/10.1016/j.mce.2016.12.004, hdl.handle.net/1765/94888
Journal Molecular and Cellular Endocrinology
Poplawski, P. (Piotr), Rybicka, B. (Beata), Boguslawska, J. (Joanna), Rodzik, K. (Katarzyna), Visser, T.J, Nauman, A. (Alicja), & Piekielko-Witkowska, A. (Agnieszka). (2017). Induction of type 1 iodothyronine deiodinase expression inhibits proliferation and migration of renal cancer cells. Molecular and Cellular Endocrinology, 442, 58–67. doi:10.1016/j.mce.2016.12.004